258 patients with dysplastic cervical lesions reclassified as cin 1-3 and aim 1-3 and with up to ten years of follow-up were immunostained with monoclonal antibodies against blood group isoantigens and involucrin for expression in normal and dysplastic squamous epithelium .
C0349458
cin 1
C0334044
dysplastic